Trend Press Wire

Transfusion Technology Market is Heading Up 7,138 Million US$ By 2026

Press release   •   Aug 12, 2019 01:42 EDT

The global Transfusion Technology Market Size is anticipated to around US$ 7,138 Million by 2026. The market is anticipated to grow at a CAGR of 5.4% from 2018 to 2026.

Market Overview:

Transfusion Technology Market 2018 - 2026 research report includes the SWOT analysis that's Strengths, Weakness, Opportunities and Threats which provides you complete analysis of competitors, market growth, market share and in addition as CAGR comparison by region. The report provides analysis of the global Transfusion Technology Market for the period from 2016 to 2026, wherein 2018–2026 is the forecast period and 2018 is the base year. Data for 2017 has been included as historical information.

The report covers all trends and technologies expected to play a major role in growth of the global Transfusion Technology Market during the forecast period. It highlights drivers, restraints, and opportunities expected to influence the market from 2018 to 2026. The study provides a holistic perspective on the Transfusion Technology Market, in terms of revenue (in US$ Mn) and volume (in million units), across different regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The report highlights key trends affecting the Transfusion Technology Market at the global level. Prominent countries/sub-regions covered in the report include the U.S., Canada, Germany, France, the U.K., Italy, Russia, India, China, Japan, South Korea, South East Asia, GCC, South Africa, and Brazil.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1194

The report comprises detailed ecosystem analysis, which provides a comprehensive view of the global Transfusion Technology Market. Porter’s five forces model has also been included to help understand the competition landscape of the market. Additionally, current indicators of diverse macro-economic factors are contextualized under key market indicators.

The report also analyzes the Transfusion Technology Market on the basis of various segments, with drug type being a prominent one. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Market Segmentation:

Market By Product

  • Instruments
    • Apheresis System & Multicomponent Collection Systems
    • Cell Processing Systems & Cell Expansion Systems
    • Auto Transfusion Devices
    • Others
  • Disposables & Consumables

Market By End-user

  • Hospitals
  • Blood Banks
  • Biotechnology & Pharmaceutical Companies
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America and Europe represented a huge offer of the worldwide transfusion technology market in 2017. This can be credited to high health care expenditure, high rate of apheresis for treatment of chronic diseases, for example, chronic kidney disease, driven by increment in the commonness of way of life related infections, rise in mindfulness about importance of careful blood, high market penetration of recently created transfusion technology gadgets, favourable reimbursement policies guaranteeing business development for new market contestants, and nearness of real players in the two areas. Notwithstanding, changes in repayment and protection approaches in 2017 and stringent administrative system for generation of medical gadgets in the U.S. are probably going to hamper the transfusion technology market in North America in the following couple of years.

Market Participants / Key Players:

LivaNova PLC., Haemonetics Corporation, Inc., Medtronic plc, TERUMO BCT, Asahi Kasei Medical Co., Ltd., MiltenyiBiotec, B. Braun Melsungen AG, GE Healthcare, Cerus Corporation, and Fresenius Kabi AG (Fresenius SE & Co. KGaA) are key companies catering in the global transfusion technology market.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, internal and external proprietary databases, relevant patent and regulatory databases, national government documents, statistical databases, market reports, news articles, press releases, webcasts specific to companies operating in the market, national government documents, statistical databases, and Factiva.

Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews conducted for each market segment across geographies. ARC conducts primary interviews on an ongoing basis with market participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competition landscape, and market outlook. These help validate and strengthen secondary research findings. They also help develop the analysis team’s expertise and market understanding.

VIEW FULL RESEARCH REPORT@ https://www.acumenresearchandconsulting.com/transfusion-technology-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Transfusion Technology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Transfusion Technology Market By Product
1.2.2.1. Global Transfusion Technology Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Transfusion Technology Market Revenue Share By Product in 2017
1.2.2.3. Instruments
1.2.2.4. Disposables & Consumables
1.2.3. Transfusion Technology Market By End-user
1.2.3.1. Global Transfusion Technology Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.3.2. Global Transfusion Technology Market Revenue Share By End-user in 2017
1.2.3.3. Hospitals
1.2.3.4. Blood Banks
1.2.3.5. Biotechnology & Pharmaceutical Companies
1.2.3.6. Others
1.2.4. Transfusion Technology Market by Geography
1.2.4.1. Global Transfusion Technology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Transfusion Technology Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Transfusion Technology Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Transfusion Technology Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Transfusion Technology Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Transfusion Technology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Transfusion Technology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Transfusion Technology Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Transfusion Technology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Transfusion Technology Major Manufacturers in 2017

CHAPTER 4. PURE CASHMERE MARKET BY PRODUCT

4.1. Global Transfusion Technology Revenue By Product
4.2. Instruments
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Disposables & Consumables
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. PURE CASHMERE MARKET BY END-USER

5.1. Global Transfusion Technology Revenue By End-user
5.2. Hospitals
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Blood Banks
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Biotechnology & Pharmaceutical Companies
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA PURE CASHMERE MARKET BY COUNTRY

6.1. North America Transfusion Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Transfusion Technology Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Transfusion Technology Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE PURE CASHMERE MARKET BY COUNTRY

7.1. Europe Transfusion Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Transfusion Technology Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC PURE CASHMERE MARKET BY COUNTRY

8.1. Asia-Pacific Transfusion Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Transfusion Technology Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA PURE CASHMERE MARKET BY COUNTRY

9.1. Latin America Transfusion Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Transfusion Technology Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST PURE CASHMERE MARKET BY COUNTRY

10.1. Middle East Transfusion Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Transfusion Technology Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA PURE CASHMERE MARKET BY COUNTRY

11.1. Africa Transfusion Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Transfusion Technology Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. LivaNova PLC.
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Haemonetics Corporation, Inc.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Medtronic plc
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. TERUMO BCT
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Asahi Kasei Medical Co., Ltd.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. MiltenyiBiotec
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. B. Braun Melsungen AG
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. GE Healthcare, Cerus Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Fresenius Kabi AG (Fresenius SE & Co. KGaA)
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1194

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.